Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors

B. Bjornhart; M. Mouritzen; C. Kristiansen; K. H. Holmskov; K. Wedervang; T. L. Jorgensen; J. Herrstedt; M. Pohl; T. Schytte

doi:10.1016/j.annonc.2022.07.1239

Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors

B. Bjornhart, M. Mouritzen, C. Kristiansen, K. H. Holmskov, K. Wedervang, T. L. Jorgensen, J. Herrstedt, M. Pohl, T. Schytte

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	1114P
Journal	Annals of Oncology
Volume	33
Issue number	Suppl. 7
Pages (from-to)	S1060
ISSN	0923-7534
DOIs	https://doi.org/10.1016/j.annonc.2022.07.1239
Publication status	Published - Sep 2022
Event	ESMO Congress 2022 - Paris Expo Porte de Versailles, Paris, France Duration: 9 Sep 2022 → 13 Sep 2022 https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2022

Conference

Conference	ESMO Congress 2022
Location	Paris Expo Porte de Versailles
Country/Territory	France
City	Paris
Period	09/09/2022 → 13/09/2022
Internet address	https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2022

Bibliographical note

Abstract No. 1114P

Access to Document

10.1016/j.annonc.2022.07.1239

Cite this

Bjornhart, B., Mouritzen, M., Kristiansen, C., Holmskov, K. H., Wedervang, K., Jorgensen, T. L., Herrstedt, J., Pohl, M., & Schytte, T. (2022). Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors. Annals of Oncology, 33(Suppl. 7), S1060. [1114P]. https://doi.org/10.1016/j.annonc.2022.07.1239

@article{b90fc9e05c4547309d6349ba01c7d8c2,

title = "Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors",

author = "B. Bjornhart and M. Mouritzen and C. Kristiansen and Holmskov, {K. H.} and K. Wedervang and Jorgensen, {T. L.} and J. Herrstedt and M. Pohl and T. Schytte",

note = "Abstract No. 1114P; ESMO Congress 2022 ; Conference date: 09-09-2022 Through 13-09-2022",

year = "2022",

month = sep,

doi = "10.1016/j.annonc.2022.07.1239",

language = "English",

volume = "33",

pages = "S1060",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "Suppl. 7",

url = "https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2022",

}

Bjornhart, B, Mouritzen, M, Kristiansen, C, Holmskov, KH, Wedervang, K, Jorgensen, TL, Herrstedt, J, Pohl, M & Schytte, T 2022, 'Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors', Annals of Oncology, vol. 33, no. Suppl. 7, 1114P, pp. S1060. https://doi.org/10.1016/j.annonc.2022.07.1239

TY - ABST

T1 - Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors

AU - Bjornhart, B.

AU - Mouritzen, M.

AU - Kristiansen, C.

AU - Holmskov, K. H.

AU - Wedervang, K.

AU - Jorgensen, T. L.

AU - Herrstedt, J.

AU - Pohl, M.

AU - Schytte, T.

N1 - Abstract No. 1114P

PY - 2022/9

Y1 - 2022/9

U2 - 10.1016/j.annonc.2022.07.1239

DO - 10.1016/j.annonc.2022.07.1239

M3 - Conference abstract in journal

VL - 33

SP - S1060

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - Suppl. 7

M1 - 1114P

T2 - ESMO Congress 2022

Y2 - 9 September 2022 through 13 September 2022

ER -